Insulin injection

Sort By: Name QualificationsPosition
(Reset)
MSc
PhD student, VU University Medical Center, Department of Medical Psychology

Van der Boechorststraat 7 (room G-417) 1081BT, Amsterdam, The Netherlands

+3120 444 8352

t.wieringa@vumc.nl

Researching the development in PROs after initiation of insulin glargine-300, decision aids for implementation of Shared Decision Making in chronic care and develop a talking and diagnostic tool for diabetes distress in type 2 diabetic patients. My PhD-project is called “Optimizing Patient-relevant outcomes with Toujeo (insulin glargine 300 U/ml) IN routine diabetes care” (OPTIN-D).
MD, FRECPEdin
Professor of Endocrinology and Metabolism, Head of the Endocrine Department, Avicenne Hospital

Service d’Endocrinologie, Hôpital Avicenne, 125 route de Stalingrad 93000, Bobigny, France

University Paris 13, Sorbonne Paris Cité, Avicenne Hospital, Bobigny, France

+33 6 60 84 53 25

Gerard.reach@aphp.fr

Endocrinologist, Diabetologist
,
MB BChir MA PhD FRCP FHEA
Professor in Diabetes and Endocrinology, University of Southampton

The Institute of Developmental Sciences (IDS Building), MP887, University of Southampton, Southampton General Hospital, Tremona Road, Southampton SO16 6YD UK

+44 23 8120 4665

righ@soton.ac.uk

Clinical Academic
BSC (Hons), DClinPsych
Consultant Clinical Psychologist, Belfast City Hospital. Honorary Lecturer, Queen’s University Belfast. Belfast Health & Social Care Trust.

Clinical Psychology Department, Belfast City Hospital, 95 Lisburn Road, Belfast, BT9 7AE

00 44 (0) 28950 49854

Mark.davies@belfasttrust.hscni.net

Clinical psychologist specialising in diabetes
BSc (hons) Psychology, MSc Health Psychology, PhD Health Sciences
Research Associate, University College London

Research Department of Clinical, Educational and Health Psychology, University College London, 1-19 Torrington Place, London, United Kingdom WC1E 7HB

+44(0)20 7674 1787

k.dennick@ucl.ac.uk

Researcher